Delivery Order SPE2DE24D0013-SPE2D626F935B
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- This delivery order, valued at $12,780, was awarded to Cepheid Inc. on December 2, 2025, by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency. The contract represents a firm fixed-price delivery order with no set-aside designation for diagnostic testing supplies and reagents, with an ultimate completion date of December 9, 2025. Cepheid, headquartered in Sunnyvale, California, is a leading manufacturer of molecular diagnostic systems, particularly its...
- This delivery order, valued at $6,800, was awarded to Cepheid Inc. on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed at Cepheid's Sunnyvale, California facility by September 11, 2025. The award carries a firm fixed-price structure with no set-aside designation, indicating competitive procurement....
- The U.S. Defense Department's Medical Supply Chain division awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. (Sunnyvale, CA) on April 23, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated XPCOV2/FLU/RSV-10, carries an ultimate completion date of April 30, 2025, and involves no set-aside provisions. This delivery order represents procurement activity under Cepheid's existing indefinite...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $10,000 firm fixed-price delivery order on November 24, 2025, for COVID-19, influenza, and respiratory syncytial virus diagnostic supplies. The delivery order, valued at the ceiling amount, is scheduled for completion by December 2, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's...
- This delivery order, valued at $40,800, was awarded to Cepheid Inc. on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the provision of molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 2, 2025. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a $4,198.65 firm fixed-price delivery order (Contract No. 4569971781) from the Defense Logistics Agency Medical Supply Chain on November 10, 2025, for respiratory pathogen diagnostic supplies related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The delivery order is scheduled for completion by November 18, 2025, and carries no set-aside designation. The award...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F935BDelivery Order
This delivery order, valued at $34,225.20, was awarded on December 8, 2025, by the Defense Logistics Agency's Medical Supply Chain to Cepheid Inc. for molecular diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus detection. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by December 15, 2025. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and reagents, with particular expertise in its GeneXpert diagnostic platform used across multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. This delivery order likely represents a task order issued under one of Cepheid's existing indefinite delivery contracts with the federal government, which serve as the primary mechanism for procuring molecular diagnostic testing solutions across the federal healthcare system. Cepheid maintains substantial contract vehicles including a $32.8 million indefinite delivery contract with Veterans Affairs Integrated Service Network 6 extending through September 2030, demonstrating the company's critical role as a core supplier of diagnostic reagents, test kits, and associated services to support federal clinical laboratory operations and infectious disease testing requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.2k | 12/7/25 |